BRANFORD, Conn., April 08, 2026--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSI" or the "Company"), a proteomics technology company redefining protein analysis through ...
Proteus™ platform development including recent development data A long-term technology roadmap that addresses the path to billions of reads The path to coverage of all 20 amino acids A suite of ...
Management is intentionally transitioning 2026 into a 'market preparation' year, prioritizing the upcoming Proteus launch over maximizing near-term Platinum Pro capital sales. Performance in Q4 2025 ...
Hosted on MSN
Quantum-Si outlines continued placement-driven growth and Proteus launch milestones as market pressures persist
The company expects adjusted operating expenses for 2025 to be $96 million or less and total cash use to be $103 million or less. Keyes noted, "this updated number of $103 million is inclusive of the ...
BRANFORD, Conn. - Quantum-Si Incorporated (NASDAQ:QSI) announced it has completed sequencing multiple customer samples on its Proteus prototype system, according to a press release statement. The ...
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a proteomics technology company redefining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results